**Participation in the National R&D Project for "Implantable Medical Devices"**  

MST(KOREA) CO., LTD. (MST, Chairman: Woongsig Moon, [www.BioCleanAct.com](http://www.BioCleanAct.com), Brand: BioCleanAct™) Central Research Institute was selected for the **Regional Specialized Industry Promotion + (R&D) Regional Star Enterprise Promotion Project** and has been conducting a **national research and development project for two years (2023–2024).**  

**[Development of a high-pressure 5Fr, 325psi peripherally inserted central catheter (PICC) for the prevention of bloodstream infections using a natural compound-based TPU antibacterial compound]**  

MST successfully carried out and completed a **national R&D commercialization project** for an **Infection-free implantable PICC** incorporating its **natural compound-based antibacterial material.**  

Furthermore, MST's **new natural antibacterial material** (for secondary bacterial infection prevention) has been the subject of joint research and development in the medical device sector with:  

- Kuraray Group Medical Division (Japan)  

- Siemens Healthineers (Germany)  

- Samsung Electronics Medical Division  

- Sewoon Medical, and others.

Secondary bacterial infection free and antibacterial medical equipment for commercial human insertion.

1. Antimicrobial Polycatheter

2. Antimicrobial Intensive Care Mouse Pad

3. Antimicrobial solution infusion set

4. Antibacterial EVD Cardatter

5. Antibacterial cerebrospinal drain tube

It has a variety of lights.